Data-driven Marketing Approaches
Preetha Vasanji, President-Emerging Markets, Doceree
1. Can you provide an overview of your journey in the healthcare communications and marketing sector?
My journey in healthcare communications and marketing began at McCann Health in Mumbai about two decades ago, where I eventually became the General Manager, leading a team of over 30 professionals. I met many extraordinary minds there, one of which was Harshit Jain MD. I joined him in his venture Doceree in 2020. Currently, as President of Emerging Markets at Doceree, I oversee expansion across the UK, India, GCC, and APAC, focusing on advanced data analytics and digital marketing to enhance physician engagement.
My career is marked by collaborations with diverse organizations, a specialization in business and people management, and a passion for innovation. Outside of work, I enjoy gardening, culinary exploration, and speaking on topics such as Medical Marketing and Tech/AI in Healthcare Marketing.
2. How has the role of data in marketing evolved over the last two decades, particularly in the pharmaceutical industry?
The evolution of data usage in pharmaceutical and healthcare marketing has been transformative, moving from broad, generic campaigns till about 5-6 years ago, to highly targeted and personalized strategies today. Initially, marketing efforts were majorly based on limited market research and anecdotal evidence, resulting in one-size-fits-all approaches. Today, advancements in data analytics have revolutionized this landscape by enabling real-time, granular insights into patient behaviors, healthcare professional preferences, and market trends.
This shift has facilitated more precise targeting, personalized communications, and effective resource allocation, all while ensuring regulatory compliance and optimizing ROI. As a result, data today has become the center point of modern pharmaceutical and healthcare marketing, driving more informed decision-making and better healthcare outcomes.
3. What key trends are currently shaping data-driven marketing strategies in the pharma sector?
Looking at Europe, key trends shaping data-driven pharmaceutical marketing strategies include the growing emphasis on personalized medicine, enhanced regulatory frameworks, and the integration of advanced digital tools into marketing strategies.
Personalized medicine is driving marketers to leverage data for creating highly tailored campaigns that address specific patient needs and preferences, ensuring more relevant and impactful messaging.
Additionally, the rise of digital health technologies and real-time evidence is fueling the use of advanced analytics and AI to gain deeper insights into HCP and patient journeys and treatment outcomes.
Today, marketers are increasingly focused on understanding healthcare professionals' (HCPs) digital presence and behavior to deliver patient-centric messaging that resonates, rather than exposing them to irrelevant information. By analyzing HCPs' online activities and preferences, marketers are today crafting tailored, meaningful messages that align with their specific interests and needs, thereby enhancing HCP-Patient conversations.
These trends collectively contribute to more precise targeting, improved HCP-patient conversations, and optimized marketing strategies within the evolving European healthcare landscape.
4. In your experience, what are the primary benefits of adopting a data-driven marketing strategy in the pharmaceutical industry?
Opting for data-driven marketing strategies in the pharmaceutical landscape addresses several critical challenges effectively.
A connected healthcare ecosystem: The foremost improvement is in connecting the scattered elements of the healthcare ecosystem. For an industry that generates vast amounts of data, data-driven strategies can truly transform operations.
Precision targeting with better outcomes: By leveraging data optimally and securely, pharmaceutical marketers can precision-tailor their messaging to align with HCPs prescribing patterns and behaviors. This ensures that communications drive outcome-led engagements, effectively elevating HCP-patient conversations and resulting in better health outcomes.
Improved Campaign ROI: Moreover, this approach facilitates the optimal allocation of marketing resources, enabling pharmaceutical manufacturers to maximize their campaign ROI by targeting efforts and investments where they matter most.
Clinical trials: Data-driven strategies can also fast-track and improve clinical trials, addressing a long-standing challenge in the pharmaceutical industry.
Regulatory compliance: Data-driven strategies support adherence to regulatory requirements by providing insights into compliance. This enables the crafting of accurate, regulation-aligned messaging, reducing the risk of violations and ensuring ethical marketing practices.
5. Can you describe how data-driven marketing helps in enhancing team productivity and decision-making?
It is widely recognized today that data driven strategies can significantly elevate comprehensive consumer analysis as well as resource allocation optimization, and help create purpose-driven campaigns. When multiple departments within a company collaborate, data plays a crucial role in aligning their efforts towards a common goal. Strategies grounded in robust data facilitate better decision-making, making it easier to understand audiences, target them effectively, personalize campaigns, and ensure reach, all of which improve ROI. This data-driven approach allows marketers to focus more on outcomes rather than tactics, ultimately enhancing the efficiency and impact of their campaigns.
6. How does data influence the conceptualization and launch phases of marketing campaigns?
In the initial phases of marketing campaigns, data is essential in identifying and segmenting target audiences, analyzing marketing trends & establishing campaign objectives that meet with business goals. During launch phase, data helps in analyzing gasps from previous campaigns, opportunities from marketing trends and helps identifying the right platforms for campaign to be run on. Additionally, data guides the content, design, timing, frequency of the ‘messaging’ by providing insights on HCP preferences, behavior.
Moreover, data-based testing and optimization guarantee the utilization of the most efficient channels and strategies, with instant adjustments possible by real-time analytics to improve campaign effectiveness.
7. What specific types of data are most valuable for pharma marketing teams when planning and executing campaigns?
As a marketer, I believe that the most important data is that of the customers. In healthcare marketing, this means focusing on healthcare professionals (HCPs). Knowing your HCP is crucial for any marketing effort to succeed. It's essential to understand what drives your target HCP to prescribe, what content they consume and where, their habits, daily routines, and activities on social and HCP networking platforms, as well as on platforms where they interact with patients. Essentially, understanding their entire digital footprint is key. With this data, a pharma marketer is well-equipped to launch a successful campaign.
8. Could you provide an example of a successful data-driven marketing campaign you have overseen? What were the key metrics used to measure its success?
One of the best data-driven marketing campaigns that we executed at Doceree was for a large pharmaceutical manufacturer that was aiming to promote a new diabetes medication. We used our platform to segment the targeting based on specialty, prescribing behaviors, and engagement pattern with prior digital insights. We personalized the messaging using real-time behavioral analysis and delivered it through the touchpoints most visited by the target HCPs-professional networks and medical journals. It was dynamic content that changed according to the recipient's interactions to be relevant and engaging. We saw huge campaign success, not just in terms of reach, but we could also measure HCPs’ intent to prescribe the drug with our I2P solution.
9. How does data-driven marketing enable more focused and customized marketing approaches?
Effective use of data allows marketers to analyze an HCP’s practice area and prescribing behaviors, revealing which specialties they focus on, their preferred medications, and their typical patient demographics. By leveraging this data, marketers can craft highly targeted and relevant messages, ensuring that communications align with the HCP’s specific interests and practice patterns. The idea is to be where the HCP is and show him the messaging that he’d prefer. This approach not only sharpens message relevance but also offers the flexibility to customize content according to the HCP’s preferences, enhancing engagement and effectiveness.
10. In what ways does reaching customers where they are and offering a better overall experience impact campaign effectiveness and ROI?
In pharmaceutical marketing, the primary audience for any campaign is the HCP, an individual who is extremely busy and makes critical decisions for their patients. Capturing the attention of such a highly engaged audience is not only challenging but also a responsibility, as these decisions can be life-saving for patients.
By reaching an HCP at a relevant time with a relevant message, right where they are attending to their patients, marketers can add significant value to the care-giving process. This targeted approach greatly increases the chances of script or intent lifts, thereby driving better ROI.
11. What are the common challenges faced by pharma companies when implementing data-driven marketing strategies, and how can these challenges be mitigated?
Data Compliance: The pharmaceutical landscape is inherently tied to the responsibility of abiding by multiple rules and regulations, preventing fraud, and ensuring data privacy and security. Compliance with various regulations is crucial for ethical marketing and patient privacy, necessitating collaboration with regulatory and legal bodies to stay updated. A robust compliance process and comprehensive documentation are a must to avoid such challenges.
Data Privacy: In programmatic advertising, which relies heavily on data, safeguarding this data is paramount. Organizations must adhere to regulations like GDPR in the European Union, protecting patient information through partnerships with reputable vendors, implementing data protection measures, and obtaining patient consent. Additionally, preventing ad fraud is critical; marketers should adopt proactive strategies, collaborate with trustworthy platforms and ad exchanges, and continuously monitor ad placements to uphold brand integrity and avoid safety challenges.
Data Consolidation: With data abundance in the healthcare and pharmaceutical industry, it becomes important to look for partners/platforms/solutions that help integrate all data together to give a one-stop solution for all and effective data usages.
Author Bio
Preetha Vasanji is a distinguished member of the senior management team at Doceree, where she serves as President – Emerging Markets. With an extensive career spanning over two decades in the Healthcare Communications and Marketing sector, Preetha brings a wealth of experience and expertise to her role. Throughout her illustrious career, Preetha has had the privilege of collaborating with numerous multinational and domestic organizations, enriching her professional journey with diverse perspectives and insights.
